Technology advancement driving growth of rapid sterility testing market
European Pharmaceutical Review
APRIL 17, 2024
billion in 2023 to $4.3 It is expected hold a compound annual growth rate (CAGR) of 8.20 percent between 2023 and 2032. Furthermore, an increasing demand for the previously mentioned dosage forms is a key factor contributing to the expansion of the market. billion by 2032.
Let's personalize your content